Name of organisation
1) Department/Research groupPharmacoepidemiology Unit - National Centre for Epidemiology, Surveillance and Health Promotion
2) Organisation/affiliationIstituto Superiore di Sanità (ISS)
Short Name in the inventoryPharmacoepidemiology Unit - ISS
Administrative Contact
Title Dr
Last name Traversa
First name Giuseppe
Address line 1Viale Regina Elena 299
Address line 2
Address line 3
CityRoma
Postcode00161
CountryItaly
Phone number (incl. country code)390649904253
Alternative phone number393294435311
Fax number (incl. country code)390649904248
Scientific Contact
Title Dr
Last name Traversa
First name Giuseppe
Address line 1Viale Regina Elena 299
Address line 2
Address line 3
CityRoma
Postcode00161
CountryItaly
Phone number (incl. country code)390649904253
Alternative phone number393294435311
Fax number (incl. country code)390649904248
Alternative Scientific Contact
Title Ms
Last name Menniti-Ippolito
First name Francesca
Address line 1Viale Regina Elena 299
Address line 2
Address line 3
CityRoma
Postcode00161
CountryItaly
Phone number (incl. country code)390649904252
Alternative phone number
Fax number (incl. country code)390649904248
2. Description
The Istituto Superiore di Sanità (ISS) is the leading technical and scientific public body of the Italian National Health Service. Its activities include research, control, training and consultation in the interest of public health protection. Fifteen departments represent the organizational structure of the ISS. With regard to human medicines, the following Departments are involved: Therapeutic Research and Medicines Evaluation; Infectious, Parasitic and Immune-Mediated Diseases; Cell Biology and Neurosciences; Center for Immunobiologicals Research and Evaluation; National Blood Centre; National Centre for Epidemiology, Surveillance and Health Promotion. The latter Centre includes the Pharmacoepidemiology Unit.
3. Category
Government based
4. Available resources
In houseVia Contacts/Network
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Disorders of the central nervous system
Endocrine disorders
Gastrointestinal tract
Geriatrics
Immunological products and vaccines
Infectious diseases
Liver disease
Paediatrics
Poisoning/Overdose
Skin disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Meta-Analysis
case series study
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Less than 5
Number of patients/respondents involved in the study(ies)
Between 1500 and 14999
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
No
Electronic data capture systems
No
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
Prescription and hospitalization data in the Umbria Region3
Prescription data in the Lazio Region1
11. Registries established by centre
Drug RegistryUsers of cholynesterase inhibitors in Italy in collaboration with the Italian Medicines Agency
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
None